News | July 31, 2023
Biogen to acquire Reata Pharmaceuticals
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Urges Innovators to produce quality products that can be deployed at scale
Construction will begin this year with the new capacity anticipated by 2025
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
Subscribe To Our Newsletter & Stay Updated
